CME Group: Piper Sandler maintains Overweight, PT raised to $296 from $283.
ByAinvest
Tuesday, Jul 15, 2025 10:37 am ET1min read
CME--
The upgrade comes amidst a period of strong performance for CME Group. The company reported earnings of $2.80 EPS for the quarter, surpassing the consensus estimate of $2.61. The stock has also shown resilience, with a twelve-month high of $290.79 and a twelve-month low of $193.25. Additionally, CME Group has seen an increase in institutional ownership, with 87.75% of the stock held by institutional investors.
Piper Sandler's decision to raise its price target reflects the brokerage's optimism about the company's future prospects. The new target price of $296 implies a substantial 4.4% upside to the stock's last close. This upgrade comes on the heels of several other positive developments, including increased insider buying and a series of analyst upgrades.
Investors should also note that CME Group recently announced a quarterly dividend of $1.25 per share, paid on Wednesday, June 25th. This represents an annualized dividend of $5.00 and a yield of 1.80%, indicating the company's commitment to shareholder returns.
Overall, the combination of strong earnings, increased institutional ownership, and analyst upgrades has positioned CME Group as a favorable investment option. Piper Sandler's upgraded rating and higher price target further reinforce this sentiment.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-patrick-mauro-investment-advisor-inc-has-1335-million-position-in-cme-group-inc-nasdaqcme-2025-07-15/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3T51BA:0-fvcbankcorp-gets-overweight-rating-as-piper-sandler-resumes-coverage/
PIPR--
CME Group: Piper Sandler maintains Overweight, PT raised to $296 from $283.
In a recent update, Piper Sandler has maintained its "overweight" rating on CME Group Inc. (NASDAQ:CME) while significantly raising its price target from $283 to $296. This move underscores the brokerage's bullish sentiment on the financial services provider, which operates contract markets for futures and options on futures contracts worldwide.The upgrade comes amidst a period of strong performance for CME Group. The company reported earnings of $2.80 EPS for the quarter, surpassing the consensus estimate of $2.61. The stock has also shown resilience, with a twelve-month high of $290.79 and a twelve-month low of $193.25. Additionally, CME Group has seen an increase in institutional ownership, with 87.75% of the stock held by institutional investors.
Piper Sandler's decision to raise its price target reflects the brokerage's optimism about the company's future prospects. The new target price of $296 implies a substantial 4.4% upside to the stock's last close. This upgrade comes on the heels of several other positive developments, including increased insider buying and a series of analyst upgrades.
Investors should also note that CME Group recently announced a quarterly dividend of $1.25 per share, paid on Wednesday, June 25th. This represents an annualized dividend of $5.00 and a yield of 1.80%, indicating the company's commitment to shareholder returns.
Overall, the combination of strong earnings, increased institutional ownership, and analyst upgrades has positioned CME Group as a favorable investment option. Piper Sandler's upgraded rating and higher price target further reinforce this sentiment.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-patrick-mauro-investment-advisor-inc-has-1335-million-position-in-cme-group-inc-nasdaqcme-2025-07-15/
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3T51BA:0-fvcbankcorp-gets-overweight-rating-as-piper-sandler-resumes-coverage/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet